NCT05044273 Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
| NCT ID | NCT05044273 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jung-min Ahn |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2022-09-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.
Eligibility Criteria
Inclusion Criteria: * Patients ≥ 19 years old * Patients receiving Synergy XD stent(s) or Synergy Megatron™ stent(s). * The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: * Patients with a mixture of other drug-eluting stents (DESs) * Terminal illness with life-expectancy ≤1 year. * Patients with cardiogenic shock
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05044273 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05044273 currently recruiting?
Yes, NCT05044273 is actively recruiting participants. Contact the research team at cvcrc5@amc.seoul.kr for enrollment information.
Where is the NCT05044273 trial being conducted?
This trial is being conducted at Anyang, South Korea, Busan, South Korea, Busan, South Korea, Busan, South Korea and 11 additional locations.
Who is sponsoring the NCT05044273 clinical trial?
NCT05044273 is sponsored by Jung-min Ahn. The trial plans to enroll 2,000 participants.